We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO...
Read ArticleWhen it comes to cancer diagnostics, the ‘tried and trusted’ methods are often not the best ones, bu...
Read ArticleDisclosure: The authors of this article and owners of Next Investors, S3 Consortium Pty Ltd, and ass...
Read ArticleLocal stocks end up posting a solid session on Monday, following some steady gains on Wall Street on...
Read ArticleThe Inoviq Ltd (ASX: IIQ) share price is racing higher during early Friday afternoon. This comes af...
Read ArticleVideo technology company BirdDog Technology (ASX:BDT) completed an ASX listing less than a week befo...
Read ArticleThe BARD1 Life Sciences Limited (ASX: BD1) share price isn’t going anywhere on Thursday. In fact, t...
Read ArticleASX recovered some lost ground in arvo trade but still finished 0.54% down, as markets continue to b...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price was a very strong performer on Friday. At one st...
Read ArticleThe ASX had a positive finish to the week although it is in negative territory for the week. The ASX...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is rocketing on Friday morning. This comes after...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleOur new business model is to research, analyse, and invest in up and coming small cap ASX-listed bio...
Read ArticleThe ASX 200 health stocks index (XHJ) has lifted by 0.46% at the time of writing, compared to the br...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price has walked through today’s session in the green....
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is slipping after the company released its lates...
Read ArticleChairman Dr Geoff Cumming said: “The capital raising was strongly supported by new and existing inst...
Read ArticleIn late afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a s...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is deep in negative territory late this afternoo...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is frozen today as the company prepares to annou...
Read ArticlePreclinical stage company, Nyrada (ASX:NYR), announced major progress today in the fight on choleste...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price has been a strong performer on Tuesday morning....
Read ArticleTech gains on Wall Street amid fears of COVID-19 spike Growth stocks were the winners on Wall Street...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSummary The S&P/ASX200 plummets 1.70% to 6945 amid broad-based selling. All 11 sectors were...
Read ArticleBARD1 Life Sciences Ltd (ASX: BD1) shares are galloping into the green today. This follows the comp...
Read ArticleBiotech company BARD1 Life Sciences (ASX:BD1) just launched its latest product, RUO EXO-NET, at the...
Read ArticleSummary Oncology firm Telix Pharmaceuticals has entered into an exclusive commercial distributio...
Read ArticleThe positive start to the week has continued for ASX stocks. The ASX 200 closed at 7,066, 0.60 per c...
Read ArticleA series of ASX announcements has attracted investors to the biotech sector today, lifting the share...
Read ArticleSummary PPK Group’s 48% owned subsidiary, Li-S Energy Limited has developed a revolutionary lith...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is in the green today, adding to strong yearly g...
Read ArticleSource: Ratanapon Srisuneton, Shutterstock Summary Universal Biosensors has entered into exclus...
Read ArticleThe BARD1 Life Sciences Limited (ASX: BD1) share price rocketed 9.71% on opening today after the co...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleSource:WHYFRAME, Shutterstock Summary Huge market volatility has been observed in 2021 so far a...
Read ArticleSource: Blue Planet Studio, Shutterstock Summary Oncology player Race Oncology has collaborated...
Read ArticleSource: CI Photos, Shutterstock Summary BARD1 Life Sciences unveiled encouraging results from a...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSource: CI Photos, Shutterstock Summary ASX-listed leading immunotherapy developer Immutep Limi...
Read ArticleBard1 Life Sciences (ASX:BD1) has surged again with news its technology can detect another cancer. I...
Read ArticleThe BARD1 Life Sciences (ASX: BD1) share price is on watch today after positive results from the ev...
Read ArticleBARD1 Life Sciences Ltd (ASX: BD1) shares are climbing today following a favourable outcome for the...
Read ArticleIn February, ASX fintech stocks were winners, losers and winners again. The benchmark ASX 200 index...
Read ArticleThe small-cap space is always filled with explosive ASX shares looking to emerge as the next big th...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price fell off its perch today after the company annou...
Read ArticleBARD1 Life Sciences (ASX:BD1) shares have slipped, after news its two founders have sued the cancer...
Read ArticleLast Thursday, the share price of BARD1 Life Sciences Ltd [ASX:BD1] had a massive breakout. Surging...
Read ArticleSummary Australia-based medical diagnostics player BARD1 Life Sciences disclosed that its SubB2M...
Read ArticleBARD1 Life Sciences Ltd (ASX: BD1) shares are rocketing higher again today following the company’s...
Read ArticleBard1 (ASX:BD1) has picked up its run where it left off last week as investors hailed its latest cli...
Read ArticleDespite their rather unusual moniker, BARD1 Life Sciences Ltd [ASX:BD1] is making a name for themsel...
Read ArticleThe BARD1 Life Sciences Ltd (ASX: BD1) share price is up an eye-popping 66% at the time of writing....
Read ArticleShares in cancer diagnostics company Bard1 (ASX:BD1) doubled this morning after new data was release...
Read ArticleBARD1 Life Sciences (ASX: BD1) has unveiled “outstanding” preliminary test results showing its licen...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralian medical technology companies Bard1 Life Sciences (ASX:BD1) and Sienna Cancer Diag...
Read ArticleMedical technology companies Bard1 Life Sciences (ASX: BD1) and Sienna Cancer Diagnostics (ASX: SDX)...
Read ArticleBARD1 Life Sciences (ASX:BD1), a medical technology company developing non-invasive cancer d...
Read ArticleYesterday, Stockhead reviewed the small caps that are devising treatments to fight cancer. There are...
Read ArticleDid you know that on this day last year those of you that were on this list at that time were given...
Read ArticleBARD1 Life Sciences (ASX:BD1), a medical technology company developing non-invasive cancer d...
Read ArticleThe science of Regenerative Medicine is a rapidly emerging field linking the medical technology, bio...
Read ArticleEric Sprott is one of the world’s most prominent resources investors. Stockhead has decided to find...
Read ArticleShort & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorte...
Read ArticleWhen your stock crashes you have three options: run away (and wait to claim the tax loss), sit still...
Read ArticleIn order to gain returns from the stock market, it is very important for investors to keep a track o...
Read ArticleMedical science company Medlab Clinical (ASX: MDC) is steadily ticking boxes as it seeks regulatory...
Read ArticlePerth-based BARD1 Life Sciences (ASX:BD1), a medical technology company developing non-invas...
Read ArticleBARD1 Life Sciences Limited (ASX:BD1) has both lung and ovarian cancer in its sights.
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
